Cristin-resultat-ID: 951892
Sist endret: 28. januar 2013, 22:30
NVI-rapporteringsår: 2012
Resultat
Vitenskapelig artikkel
2012

Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnacy in patients undergoing IVF/ICSI?

Bidragsytere:
  • Hans Ivar Hanevik
  • Mette Friberg
  • Anette Bergh
  • Caroline Haraldsen og
  • Jarl Kahn

Tidsskrift

Journal of Obstetrics and Gynaecology
ISSN 0144-3615
e-ISSN 1364-6893
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2012
Volum: 32
Hefte: 8
Sider: 786 - 789

Importkilder

Scopus-ID: 2-s2.0-84867694439
Isi-ID: 000309935900019

Beskrivelse Beskrivelse

Tittel

Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnacy in patients undergoing IVF/ICSI?

Sammendrag

The present study investigated if acetyl salicylic acid (ASA) and terbutaline in combination increased the clinical pregnancy rate in patients undergoing in vitro fertilisation (IVF)/intra-cytoplasmic sperm injection (ICSI). A randomised controlled trial was designed, in which 167 patients were randomised to taking ASA for 9 weeks after embryo transfer and terbutaline around the time of embryo transfer as adjuvant medication. A total of 112 patients were randomised to no adjuvant medication. The clinical pregnancy rate per controlled ovarian hyperstimulation was 30.5% in the intervention group and 42.0% in the control group. This difference was not statistically significant, and we conclude that ASA and terbutaline in combination do not increase the clinical pregnancy rate after IVF/ICSI treatment

Bidragsytere

Hans Ivar Hanevik

  • Tilknyttet:
    Forfatter
    ved Sykehuset Telemark HF

Mette Friberg

  • Tilknyttet:
    Forfatter
    ved Sykehuset Telemark HF

Anette Bergh

  • Tilknyttet:
    Forfatter
    ved Sykehuset Telemark HF

Caroline Haraldsen

  • Tilknyttet:
    Forfatter
    ved Sykehuset Telemark HF

Jarl Kahn

  • Tilknyttet:
    Forfatter
    ved Sykehuset Telemark HF
1 - 5 av 5